FDA — authorised 23 September 1960
- Application: NDA012541
- Marketing authorisation holder: PFIZER
- Local brand name: DEPO-PROVERA
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised DMPA on 23 September 1960
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 23 September 1960; FDA has authorised it.
PFIZER holds the US marketing authorisation.